Inside Life Sciences

Inside Life Sciences

Issue 5
A high for cannabidiol

A high for cannabidiol

There has been a huge amount of press interest very recently in medical cannabis, its effects, and whether it should be legalised.

Read more
Pfizer and Flynn win appeal against abuse of dominance decision

Pfizer and Flynn win appeal against abuse of dominance decision

The Competition Appeal Tribunal (CAT) has upheld appeals by Pfizer Limited and Flynn Pharma Limited in relation to significant fines imposed by the Competition and Markets Authority (CMA) for charging allegedly unfair prices for genericised phenytoin sodium capsules in breach of Chapter II of the Competition Act.

Read more
Advocate General issues SPC Opinion in Teva v Gilead

Advocate General issues SPC Opinion in Teva v Gilead

On 25 April, Advocate General Wathelet issued his opinion on the interpretation of Article 3(a) SPC Regulation in the referral from the UK Patents Court in Teva & ors v Gilead following a hearing before the Grand Chamber of the Court of Justice of the EU in February 2018.

Read more
SPC Reform: Commission proposes export manufacturing waiver

SPC Reform: Commission proposes export manufacturing waiver

Following a consultation, the EU Commission has published a proposal for a 'targeted amendment' to the rules relating to supplementary protection certificates (SPCs) in the form of a 'manufacturing export waiver'

Read more
Under the microscope: the gender pay gap in the life sciences sector

Under the microscope: the gender pay gap in the life sciences sector

With the first annual reporting window having closed on 4 April 2018, we look at how the life sciences sector has fared in the first year of mandatory gender pay gap reporting.

Read more
Brexit Update – Continue to prepare for a Hard Brexit

Brexit Update – Continue to prepare for a Hard Brexit

Despite the UK and EU provisionally agreeing a transitional period, the Life Sciences industry continues to heed the message, "prepare for a hard Brexit"

Read more
CJEU rules on parallel imports of medical devices

CJEU rules on parallel imports of medical devices

Whilst the law relating to the repackaging of imported pharmaceutical products is now largely settled following a series of decisions, a recent case provides further clarification.

Read more
Injunctions: an increasingly flexible and pragmatic approach

Injunctions: an increasingly flexible and pragmatic approach

In recent years, the UK courts have demonstrated that they are prepared to be flexible and pragmatic when considering remedies for patent infringement.

Read more

Previous Issues

How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

I'm a client

Please enter your first name
Please enter your last name
Please enter your enquiry
Please enter a value

I'm looking for advice

Please enter your first name
Please enter your last name
Please enter your enquiry
Please select a department
Please select a contact method

Something else

Please enter your first name
Please enter your last name
Please enter your enquiry
Please select your contact method of choice